# The Study of Reducing Adverse Effects After Radiofrequency Ablation Combined With Sclerotherapy

> **NCT05654233** · NA · UNKNOWN · sponsor: **Chengdu University of Traditional Chinese Medicine** · enrollment: 120 (estimated)

## Conditions studied

- Vascular Diseases, Peripheral
- Venous Insufficiency of Leg
- Varicose Veins of Lower Limb

## Interventions

- **DRUG:** Sulodexide

## Key facts

- **NCT ID:** NCT05654233
- **Lead sponsor:** Chengdu University of Traditional Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-01
- **Primary completion:** 2023-08-01
- **Final completion:** 2023-09-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2023-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05654233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05654233, "The Study of Reducing Adverse Effects After Radiofrequency Ablation Combined With Sclerotherapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05654233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*